ANG exchange filings, corporate actions and results
14 Aug 2026
⚑ Result
ANG Lifesciences India Ltd - 540694 - Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations, 2015BSE filing · raw filing ↗
14 Aug 2026
⚑ Result
Q1 FY27 results filed — revenue ₹15 Cr (−37.8% YoY), PAT ₹-4 Cr (−NaN% YoY)BSE filing · raw filing ↗
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
